bioRxivCell BiologyPreprint
JAZF1 is transcriptionally regulated by SOX11 and promotes cardiac fibrosis by PI3K-Akt pathway
Abstract
BackgroundCardiac fibrosis is a component of all chronic heart diseases. JAZF1 regulates metabolism through various mechanisms; however, its role in cardiac fibrosis remains unclear. We aimed to investigate the role of JAZF1 in cardiac fibrosis. MethodsA rat cardiac fibrosis model was established by administering isoproterenol subcutaneously for 14 days (5 mg/kg/day); an equal volume of saline was administered to the control group. Cardiac fibroblasts (CFs) were treated with TGF-{beta}1 for 48 h to mimic cardiac fibrosis in vitro. ResultsJAZF1 expression at the protein and mRNA levels was enhanced in CFs and cardiac fibrosis tissues. JAZF1 downregulation suppressed CFs proliferation and migration. Western blotting showed that the PI3K/Akt signaling pathway was significantly decreased after JAZF1 knockdown. Further experiments revealed that SOX11 is an important transcription factor whose overexpression and downregulation enhanced and suppressed JAZF1 levels, respectively. Luciferase analysis showed that SOX11 interacted with the JAZF1 promoter. Moreover, SOX11 promoted cardiac fibrosis by regulating JAZF1 expression. ConclusionsJAZF1 was enhanced in cardiac fibrosis tissue and TGF-{beta}-treated CFs. JAZF1 knockdown decreased CFs migration and proliferation, possibly remediated by SOX11 with activation of PI3k/Akt signaling pathways.
- organism: rat
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- FAM114A1 Influences Cardiac Fibrosis by Regulating Angiotensin II Signaling in Cardiac Fibroblasts
K. C. V. Subbaiah, J. Wu, … P. Yao·bioRxiv·Feb 20, 2021
- Interleukin 11-induced microRNAs as functional mediators and circulating biomarkers of cardiac fibrosis
Roman Tikhomirov, Veronika Boichenko, … Julia Gorelik·Circulation ResearchPeer-reviewed·Mar 17, 2026
- Cardiomyocyte-restricted expression of IL11 causes cardiac fibrosis, inflammation, and dysfunction.
Mark D. Sweeney, Katie O’Fee, … Stuart A. Cook·International Journal of Molecular SciencesPeer-reviewed·Aug 20, 2023
- AI-based Predictive Signaling Pathway Profiling in Cardiac Fibrosis Suggests a Novel Combinatorial Treatment Strategy
Bo Yang, Jie Chen, … Qinghang Meng·bioRxiv·Dec 5, 2025
- The dual PPAR-α/δ agonist elafibranor attenuates TGF-β1-induced cardiac fibrosis through redox-metabolic and bioenergetic reprogramming in human cardiac models
Milena Paw, Lukas Minder, … Gabriela Kania·bioRxiv·Aug 21, 2026
- Stimulation of cardiac fibroblast Piezo1 channels opposes myofibroblast differentiation and induces IL-6 secretion via Ca2+-mediated p38 MAP kinase activation
N. M. Blythe, V. Stylianidis, … N. A. Turner·bioRxiv·Apr 10, 2019